Marchiset-LecaDLecaFRGaleaniANobleAIliadisA. A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans. Cancer Chemother Pharmacol1995;36:233–8.
2.
SeikeMKurisakaMMoriS. Effect of combination therapy with cis-platinum (CDDP) and tetrahydropyranyladriamycin (THP-ADR) (PP therapy) for glioblastoma (in Japanese). Kiso to Rinshou1989;23:5983–6.
3.
GumerlockMKBelsheBDMadsenRWattsC. Osmotic blood—brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: Patient series and literature review. J Neurooncol1992;12:33–46.
4.
NakagawaHFujitaTHuboSTuruzonoKYamadaMTokiyoshiKSelective intra-arterial chemotherapy with a combination of etopo-side and cisplatin for malignant glioma: Preliminary report. Surg Neurol1994;41:19–27.
5.
MatsushitaYIguchiHKiyoshakiTToneHIshikuraTTakeuchiTA high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyl-adriamycin and their metabolites in biological samples. J Antibiot1983;36:880–6.
